scholarly journals Temporal trends of maternal near miss in Brazil between 2000 and 2012

2019 ◽  
Vol 19 (1) ◽  
pp. 115-124 ◽  
Author(s):  
Beatriz Aguiar da Silva Carvalho ◽  
Ana Gabriella Bandeira Freire Andrade ◽  
Andreza Saboia Dantas ◽  
Ingrid Medeiros de Figueiredo ◽  
Jéssica Alves da Silva ◽  
...  

Abstract Objectives: to identify the temporal trends and regional variations in maternal near miss in Brazil. Methods: ecological study of temporal trends. The units of analysis are in the States, the regions and Brazil, between 2000 and 2012, the dependent variable being the maternal near miss rate (MNMR), calculated from the records of the Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH-SUS) (National Health Hospital Information System).Regression analysis using Joinpoint regression software, version 4.1.0. was applied to analyze morbidity trends. Results: the main result of this study was a finding on an increase rate trend in maternal near miss in Brazil, between 2000 and 2012. This trend behaves differently depending on the development level of the region studied, presenting a positively higher increase in less developed regions and states. Conclusions: there is an increasing trend in maternal near miss rates in Brazil. The SIH-SUS may be an important instrument in identifying and monitoring maternal morbidity. Furthermore, investments in more effective public policies are needed to reduce inequalities and improve human development, both of which have influenced the chain of events related to maternal health.

2016 ◽  
Vol 1 (3) ◽  
pp. 92 ◽  
Author(s):  
ShaimaaS Abdel-Raheem ◽  
DaliaG Mahran ◽  
GhadaS. T. Al-Attar ◽  
MohammadH Qayed ◽  
ZeinE. A. Zareh ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Weng-Ming Liu ◽  
Ruey-Meei Wu ◽  
Chia-Hsuin Chang ◽  
Jou-Wei Lin ◽  
Ying-Chun Liu ◽  
...  

Background. Several guidelines for Parkinson’s disease (PD) management were recently updated. We examined temporal trends for antiparkinsonism drugs in Taiwan.Methods. Antiparkinsonism prescriptions, including levodopa, ergot/nonergot dopamine agonists (DAs), amantadine, selegiline, entacapone, and anticholinergics, were identified in the Taiwan National Health Insurance Database from 2004 to 2011. Time trend analyses were estimated assuming Poisson distribution.Results. A total of 19,302 PD patients in 2004 and 41,606 PD patients in 2011 were analyzed. Antiparkinsonism prescriptions increased significantly from 187,137 in 2004 to 414,587 in 2011. Levodopa monotherapy or combination therapy was the mainstay. Levodopa monotherapy comprised 37.4% of prescriptions in 2004 and 44.2% in 2011, with an annual increase rate of 18.14%. There was a substantially increasing trend of DA prescriptions, which were higher in younger-aged patients (<60 years) than in older-aged group (p=0.0006). Among combination therapy, DA combined with levodopa or other antiparkinsonism medications became the main combinations for younger-aged patients after 2009. After 2005, the proportion of ergot DA usage markedly decreased and PD patients using nonergot DA increased.Conclusions. Levodopa was the major treatment from 2004 to 2011. There was a steeply increased trend of DA use, especially in younger-aged patients. Nonergot agents comprised the major DA group after 2005.


2017 ◽  
Vol 2 (1) ◽  
pp. 1 ◽  
Author(s):  
ShaimaaS Abdel-Raheem ◽  
GhadaS. T Al-Attar ◽  
DaliaG Mahran ◽  
MohammadH Qayed ◽  
Zainel-AbidinZ. H Alib ◽  
...  

2020 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Magda Farahat ◽  
Manal Alshamy ◽  
entisar younes ◽  
Ahmed Abbas

2019 ◽  
Author(s):  
Natalie England ◽  
Julia Madill ◽  
Amy Metcalfe ◽  
Laura Magee ◽  
Stephanie Cooper ◽  
...  

2021 ◽  
pp. 1-14
Author(s):  
María Escobar ◽  
Claudia Mosquera ◽  
María Antonia Hincapie ◽  
Daniela Nasner ◽  
Javier Andrés Carvajal ◽  
...  

Author(s):  
Ida Erika Wieborg Von Rosen ◽  
Rayan Mohamud Shiekh ◽  
Bariki Mchome ◽  
Chunsen Wu ◽  
Khalid S. Khan ◽  
...  

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Abera Kenay Tura ◽  
To Lam Trang ◽  
Thomas van den Akker ◽  
Jos van Roosmalen ◽  
Sicco Scherjon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document